Seelos Therapeutics Inc. (NASDAQ: SEEL) Stock Information | RedChip

Seelos Therapeutics Inc. (NASDAQ: SEEL) Listen to this Section


$0.35
+0.1160 ( +49.57% ) 8.1M

Seelos Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing products that address unmet needs in Central Nervous System (CNS) disorders and other rare disorders. Its product pipeline includes SLS-002, SLS-005, SLS-004, SLS-007, and SLS-009.

Market Data


Open


$0.35

Previous close


$0.23

Volume


8.1M

Market cap


$0.77M

Day range


$0.22 - $0.43

52 week range


$0.22 - $300.00

Insider Ownership Transactions

Total Amount Purchased: 44,256.00 | $ 15,502.88

Date Type Amount Purchased Purchaser
2024-03-01 Sale -417.00 Golembiewski Michael Joseph
2024-01-17 Sale -70383.00 Mehra Raj
2024-01-17 Sale -24537.00 Golembiewski Michael Joseph
2024-01-08 Sale -1666.00 Pascoe Richard W
2024-01-08 Sale -1666.00 DALESANDRO MARGARET
2024-01-08 Sale -1666.00 Lian Brian
2024-01-08 Sale -1666.00 O'Connor Daniel J.
2023-12-01 Buy 83000.00 Golembiewski Michael Joseph
2023-12-01 Buy 75757.00 Mehra Raj
2023-09-01 Sale -12500.00 Golembiewski Michael Joseph

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 69 Aug 14, 2024
pre Proxies and info statements 3 Aug 09, 2024
8-k 8K-related 13 Aug 08, 2024
8-k 8K-related 13 Jul 26, 2024
8-k 8K-related 14 Jul 16, 2024
8-k 8K-related 16 Jul 12, 2024
8-k 8K-related 14 Jun 05, 2024
8-k 8K-related 23 May 21, 2024
8-k 8K-related 15 May 16, 2024
8-k 8K-related 15 May 14, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.